XML 21 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities      
Net income $ 2,176 $ 8,087 $ 10,204
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 1,325 1,345 1,328
Net amortization of loans and investment securities 1,730 1,617 1,659
Amortization and net change in mortgage servicing rights valuation 55 55 34
Amortization of intangibles     181
Provision for loan losses 670 3,775 1,285
Gain on sales of securities (3) (22) (8)
Impairment write-down on securities recognized in earnings   40 20
Gain on conversion of investment security     (728)
Legal reserve 10,000    
Loans originated for sale (9,887) (8,972) (9,121)
Proceeds from sale of loans 9,985 8,893 9,049
Write-down on premise and equipment available for sale 45 69 60
Write-down of other real estate owned 83 1,209 365
Net loss on sale or disposal of other real estate/other repossessed assets 26 31 (32)
Increase in cash surrender value of life insurance (521) (531) (551)
Gain from surrender of life insurance policy   (76) (103)
Stock option compensation 161 88 74
Decrease in other assets 293 1,174 2,443
Increase (decrease) in other liabilities 945 (1,094) (2,758)
Deferred tax benefit (831) (832) (111)
Net cash provided by operating activities 16,252 14,856 13,290
Cash flows from investing activities      
Proceeds from sales and calls of investment securities available for sale 1,205 3,825 1,381
Proceeds from maturities and pay-downs of securities available for sale 22,424 25,393 30,123
Purchase of investment securities available for sale (8,602) (985) (21,688)
Net decrease (increase) in restricted stock 1,311 (16,605) (344)
Net increase in loans (49,911) (114,780) (58,496)
Proceeds from sale of other real estate/other repossessed assets 2,298 625 508
Proceeds from surrender of life insurance policy   436 389
Proceeds from the sale of other assets 154    
Capital expenditures (1,119) (579) (1,041)
Net cash used in investing activities (32,240) (102,670) (49,168)
Cash flows from financing activities      
Net increase in demand deposits, interest-bearing checking, and savings accounts 64,225 74,704 50,199
Net increase (decrease) in time deposits 836 (11,096) (12,868)
Net decrease in repurchase agreements     (9,079)
Net (decrease) increase in short-term borrowings 24,270 (24,270)  
Dividends paid (4,031) (3,523) (3,139)
Purchase of Treasury shares   (795)  
Cash received from option exercises 175 82 92
Common stock issued under dividend reinvestment plan 991 1,671 1,246
Net cash provided by financing activities 37,926 85,313 26,451
Increase (decrease) in cash and cash equivalents 21,938 (2,501) (9,427)
Cash and cash equivalents as of January 1 36,665 39,166 48,593
Cash and cash equivalents as of December 31 58,603 36,665 39,166
Supplemental Disclosures of Cash Flow Information      
Cash paid during the year for: Interest on deposits and other borrowed funds 2,458 2,253 2,416
Cash paid during the year for: Income taxes 3,955 2,100 3,016
Noncash Activities:      
Loans transferred to Other Real Estate $ 90 $ 329 $ 3,626